Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...

which indicates that MSCs might be a new strategy for the treatment of immune-mediated diseases. Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal stem cells that can be isolated ...

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

2024 — Stem cell transplantation is used to treat several types of blood cancers, but carries the risk of a life-threatening side effect called graft-versus-host disease. Results from a clinical ...

Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...

Nearly 60,000 people are diagnosed with oral cancer in the U.S. every year, according to the American Cancer Society, and the ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “A case report of donor cell–derived ...

Scientists uncover how the nucleolus, a tiny structure within cells, may control aging and lifespan, opening new ...

A revolutionary approach to immune therapy has emerged: engineered immune cells that protect healthy tissue without ...

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...

Researchers find a master epigenetic switch that activates silenced genes to compensate for their missing counterparts in a ...

A University of Ottawa neuroscientist has led a Canadian research team to reveal important new insights into the activation ...